. Author manuscript; available in PMC: 2020 Dec 29.

Published in final edited form as: Urol Oncol. 2017 Jun 27;35(10):605.e17–605.e23. doi: 10.1016/j.urolonc.2017.06.001

Table 3.

Multivariable analysis for recurrence

Variable	HR	95% CI	P value
A-XRT
Yes	Referent
No	1.8	1.06–3.12	0.03
Pelvic ENE
No	Referent
Yes	1.9	1.12–3.24	0.02
Chemotherapy
None	Referent
Pre-op	0.8	0.45–1.74	0.72
Post-op	0.8	0.29–2.35	0.73
Grade
1/2	Referent
3/4	1.4	0.78–2.42	0.27
Treatment year	1.0	0.98–1.06	0.19

Bold indicates significance at P < 0.05. A-XRT = adjuvant pelvic radiation therapy; LN = lymph nodes.